The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Intramuscular HPV Vaccine Market Research Report 2024
Synopsis
The intramuscular HPV vaccine is a vaccine to prevent human papillomavirus infection. It boosts the body's immunity against papillomaviruses by injecting the vaccine into muscle tissue, which triggers an immune response.
Global Intramuscular HPV Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intramuscular HPV Vaccine market research.
The characteristics and precautions of intramuscular injection of HPV vaccine include: recommended age, vaccine dose and vaccination schedule, vaccination site, safety and side effects, catch-up and vaccination recommendations.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Intramuscular HPV Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck Sharp & Dohme (MSD)
Pfizer
Sanofi
GSK
Serum Institute
Astellas Pharma
CSL
Emergent BioSolutions
GlaxoSmithKline
Johnson & Johnson
MedImmune
Walvax Biotechnology
Liaoning Chengda Biotechnology
Hualan Biological Engineering
Sinovac Biotech
Chongqing Zhifei Biological Products
Chang Chun High and New Technology Industries (Group)
Beijing Wantai Biological Pharmacy Enterprise
Jiangsu Recbio Technology
Segment by Type
Bivalent
Quadrivalent
Nine-valent
Segment by Application
Male
Female
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Intramuscular HPV Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
The intramuscular HPV vaccine is a vaccine to prevent human papillomavirus infection. It boosts the body's immunity against papillomaviruses by injecting the vaccine into muscle tissue, which triggers an immune response.
Global Intramuscular HPV Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Intramuscular HPV Vaccine market research.
The characteristics and precautions of intramuscular injection of HPV vaccine include: recommended age, vaccine dose and vaccination schedule, vaccination site, safety and side effects, catch-up and vaccination recommendations.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Intramuscular HPV Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merck Sharp & Dohme (MSD)
Pfizer
Sanofi
GSK
Serum Institute
Astellas Pharma
CSL
Emergent BioSolutions
GlaxoSmithKline
Johnson & Johnson
MedImmune
Walvax Biotechnology
Liaoning Chengda Biotechnology
Hualan Biological Engineering
Sinovac Biotech
Chongqing Zhifei Biological Products
Chang Chun High and New Technology Industries (Group)
Beijing Wantai Biological Pharmacy Enterprise
Jiangsu Recbio Technology
Segment by Type
Bivalent
Quadrivalent
Nine-valent
Segment by Application
Male
Female
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Intramuscular HPV Vaccine report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Intramuscular HPV Vaccine Market Overview
1.1 Product Overview and Scope of Intramuscular HPV Vaccine
1.2 Intramuscular HPV Vaccine Segment by Type
1.2.1 Global Intramuscular HPV Vaccine Market Value Comparison by Type (2023-2029)
1.2.2 Bivalent
1.2.3 Quadrivalent
1.2.4 Nine-valent
1.3 Intramuscular HPV Vaccine Segment by Application
1.3.1 Global Intramuscular HPV Vaccine Market Value by Application: (2023-2029)
1.3.2 Male
1.3.3 Female
1.4 Global Intramuscular HPV Vaccine Market Size Estimates and Forecasts
1.4.1 Global Intramuscular HPV Vaccine Revenue 2018-2029
1.4.2 Global Intramuscular HPV Vaccine Sales 2018-2029
1.4.3 Global Intramuscular HPV Vaccine Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Intramuscular HPV Vaccine Market Competition by Manufacturers
2.1 Global Intramuscular HPV Vaccine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Intramuscular HPV Vaccine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Intramuscular HPV Vaccine Average Price by Manufacturers (2018-2023)
2.4 Global Intramuscular HPV Vaccine Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Intramuscular HPV Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Intramuscular HPV Vaccine, Product Type & Application
2.7 Intramuscular HPV Vaccine Market Competitive Situation and Trends
2.7.1 Intramuscular HPV Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Intramuscular HPV Vaccine Players Market Share by Revenue
2.7.3 Global Intramuscular HPV Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Intramuscular HPV Vaccine Retrospective Market Scenario by Region
3.1 Global Intramuscular HPV Vaccine Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Intramuscular HPV Vaccine Global Intramuscular HPV Vaccine Sales by Region: 2018-2029
3.2.1 Global Intramuscular HPV Vaccine Sales by Region: 2018-2023
3.2.2 Global Intramuscular HPV Vaccine Sales by Region: 2024-2029
3.3 Global Intramuscular HPV Vaccine Global Intramuscular HPV Vaccine Revenue by Region: 2018-2029
3.3.1 Global Intramuscular HPV Vaccine Revenue by Region: 2018-2023
3.3.2 Global Intramuscular HPV Vaccine Revenue by Region: 2024-2029
3.4 North America Intramuscular HPV Vaccine Market Facts & Figures by Country
3.4.1 North America Intramuscular HPV Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Intramuscular HPV Vaccine Sales by Country (2018-2029)
3.4.3 North America Intramuscular HPV Vaccine Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Intramuscular HPV Vaccine Market Facts & Figures by Country
3.5.1 Europe Intramuscular HPV Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Intramuscular HPV Vaccine Sales by Country (2018-2029)
3.5.3 Europe Intramuscular HPV Vaccine Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Intramuscular HPV Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Intramuscular HPV Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Intramuscular HPV Vaccine Sales by Country (2018-2029)
3.6.3 Asia Pacific Intramuscular HPV Vaccine Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Intramuscular HPV Vaccine Market Facts & Figures by Country
3.7.1 Latin America Intramuscular HPV Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Intramuscular HPV Vaccine Sales by Country (2018-2029)
3.7.3 Latin America Intramuscular HPV Vaccine Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Intramuscular HPV Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Intramuscular HPV Vaccine Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Intramuscular HPV Vaccine Sales by Country (2018-2029)
3.8.3 Middle East and Africa Intramuscular HPV Vaccine Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Intramuscular HPV Vaccine Sales by Type (2018-2029)
4.1.1 Global Intramuscular HPV Vaccine Sales by Type (2018-2023)
4.1.2 Global Intramuscular HPV Vaccine Sales by Type (2024-2029)
4.1.3 Global Intramuscular HPV Vaccine Sales Market Share by Type (2018-2029)
4.2 Global Intramuscular HPV Vaccine Revenue by Type (2018-2029)
4.2.1 Global Intramuscular HPV Vaccine Revenue by Type (2018-2023)
4.2.2 Global Intramuscular HPV Vaccine Revenue by Type (2024-2029)
4.2.3 Global Intramuscular HPV Vaccine Revenue Market Share by Type (2018-2029)
4.3 Global Intramuscular HPV Vaccine Price by Type (2018-2029)
5 Segment by Application
5.1 Global Intramuscular HPV Vaccine Sales by Application (2018-2029)
5.1.1 Global Intramuscular HPV Vaccine Sales by Application (2018-2023)
5.1.2 Global Intramuscular HPV Vaccine Sales by Application (2024-2029)
5.1.3 Global Intramuscular HPV Vaccine Sales Market Share by Application (2018-2029)
5.2 Global Intramuscular HPV Vaccine Revenue by Application (2018-2029)
5.2.1 Global Intramuscular HPV Vaccine Revenue by Application (2018-2023)
5.2.2 Global Intramuscular HPV Vaccine Revenue by Application (2024-2029)
5.2.3 Global Intramuscular HPV Vaccine Revenue Market Share by Application (2018-2029)
5.3 Global Intramuscular HPV Vaccine Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Merck Sharp & Dohme (MSD)
6.1.1 Merck Sharp & Dohme (MSD) Corporation Information
6.1.2 Merck Sharp & Dohme (MSD) Description and Business Overview
6.1.3 Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Merck Sharp & Dohme (MSD) Intramuscular HPV Vaccine Product Portfolio
6.1.5 Merck Sharp & Dohme (MSD) Recent Developments/Updates
6.2 Pfizer
6.2.1 Pfizer Corporation Information
6.2.2 Pfizer Description and Business Overview
6.2.3 Pfizer Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Pfizer Intramuscular HPV Vaccine Product Portfolio
6.2.5 Pfizer Recent Developments/Updates
6.3 Sanofi
6.3.1 Sanofi Corporation Information
6.3.2 Sanofi Description and Business Overview
6.3.3 Sanofi Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Sanofi Intramuscular HPV Vaccine Product Portfolio
6.3.5 Sanofi Recent Developments/Updates
6.4 GSK
6.4.1 GSK Corporation Information
6.4.2 GSK Description and Business Overview
6.4.3 GSK Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GSK Intramuscular HPV Vaccine Product Portfolio
6.4.5 GSK Recent Developments/Updates
6.5 Serum Institute
6.5.1 Serum Institute Corporation Information
6.5.2 Serum Institute Description and Business Overview
6.5.3 Serum Institute Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Serum Institute Intramuscular HPV Vaccine Product Portfolio
6.5.5 Serum Institute Recent Developments/Updates
6.6 Astellas Pharma
6.6.1 Astellas Pharma Corporation Information
6.6.2 Astellas Pharma Description and Business Overview
6.6.3 Astellas Pharma Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Astellas Pharma Intramuscular HPV Vaccine Product Portfolio
6.6.5 Astellas Pharma Recent Developments/Updates
6.7 CSL
6.6.1 CSL Corporation Information
6.6.2 CSL Description and Business Overview
6.6.3 CSL Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CSL Intramuscular HPV Vaccine Product Portfolio
6.7.5 CSL Recent Developments/Updates
6.8 Emergent BioSolutions
6.8.1 Emergent BioSolutions Corporation Information
6.8.2 Emergent BioSolutions Description and Business Overview
6.8.3 Emergent BioSolutions Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Emergent BioSolutions Intramuscular HPV Vaccine Product Portfolio
6.8.5 Emergent BioSolutions Recent Developments/Updates
6.9 GlaxoSmithKline
6.9.1 GlaxoSmithKline Corporation Information
6.9.2 GlaxoSmithKline Description and Business Overview
6.9.3 GlaxoSmithKline Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 GlaxoSmithKline Intramuscular HPV Vaccine Product Portfolio
6.9.5 GlaxoSmithKline Recent Developments/Updates
6.10 Johnson & Johnson
6.10.1 Johnson & Johnson Corporation Information
6.10.2 Johnson & Johnson Description and Business Overview
6.10.3 Johnson & Johnson Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Johnson & Johnson Intramuscular HPV Vaccine Product Portfolio
6.10.5 Johnson & Johnson Recent Developments/Updates
6.11 MedImmune
6.11.1 MedImmune Corporation Information
6.11.2 MedImmune Intramuscular HPV Vaccine Description and Business Overview
6.11.3 MedImmune Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 MedImmune Intramuscular HPV Vaccine Product Portfolio
6.11.5 MedImmune Recent Developments/Updates
6.12 Walvax Biotechnology
6.12.1 Walvax Biotechnology Corporation Information
6.12.2 Walvax Biotechnology Intramuscular HPV Vaccine Description and Business Overview
6.12.3 Walvax Biotechnology Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Walvax Biotechnology Intramuscular HPV Vaccine Product Portfolio
6.12.5 Walvax Biotechnology Recent Developments/Updates
6.13 Liaoning Chengda Biotechnology
6.13.1 Liaoning Chengda Biotechnology Corporation Information
6.13.2 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Description and Business Overview
6.13.3 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Liaoning Chengda Biotechnology Intramuscular HPV Vaccine Product Portfolio
6.13.5 Liaoning Chengda Biotechnology Recent Developments/Updates
6.14 Hualan Biological Engineering
6.14.1 Hualan Biological Engineering Corporation Information
6.14.2 Hualan Biological Engineering Intramuscular HPV Vaccine Description and Business Overview
6.14.3 Hualan Biological Engineering Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Hualan Biological Engineering Intramuscular HPV Vaccine Product Portfolio
6.14.5 Hualan Biological Engineering Recent Developments/Updates
6.15 Sinovac Biotech
6.15.1 Sinovac Biotech Corporation Information
6.15.2 Sinovac Biotech Intramuscular HPV Vaccine Description and Business Overview
6.15.3 Sinovac Biotech Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Sinovac Biotech Intramuscular HPV Vaccine Product Portfolio
6.15.5 Sinovac Biotech Recent Developments/Updates
6.16 Chongqing Zhifei Biological Products
6.16.1 Chongqing Zhifei Biological Products Corporation Information
6.16.2 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Description and Business Overview
6.16.3 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Chongqing Zhifei Biological Products Intramuscular HPV Vaccine Product Portfolio
6.16.5 Chongqing Zhifei Biological Products Recent Developments/Updates
6.17 Chang Chun High and New Technology Industries (Group)
6.17.1 Chang Chun High and New Technology Industries (Group) Corporation Information
6.17.2 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Description and Business Overview
6.17.3 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Chang Chun High and New Technology Industries (Group) Intramuscular HPV Vaccine Product Portfolio
6.17.5 Chang Chun High and New Technology Industries (Group) Recent Developments/Updates
6.18 Beijing Wantai Biological Pharmacy Enterprise
6.18.1 Beijing Wantai Biological Pharmacy Enterprise Corporation Information
6.18.2 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Description and Business Overview
6.18.3 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Beijing Wantai Biological Pharmacy Enterprise Intramuscular HPV Vaccine Product Portfolio
6.18.5 Beijing Wantai Biological Pharmacy Enterprise Recent Developments/Updates
6.19 Jiangsu Recbio Technology
6.19.1 Jiangsu Recbio Technology Corporation Information
6.19.2 Jiangsu Recbio Technology Intramuscular HPV Vaccine Description and Business Overview
6.19.3 Jiangsu Recbio Technology Intramuscular HPV Vaccine Sales, Revenue and Gross Margin (2018-2023)
6.19.4 Jiangsu Recbio Technology Intramuscular HPV Vaccine Product Portfolio
6.19.5 Jiangsu Recbio Technology Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Intramuscular HPV Vaccine Industry Chain Analysis
7.2 Intramuscular HPV Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Intramuscular HPV Vaccine Production Mode & Process
7.4 Intramuscular HPV Vaccine Sales and Marketing
7.4.1 Intramuscular HPV Vaccine Sales Channels
7.4.2 Intramuscular HPV Vaccine Distributors
7.5 Intramuscular HPV Vaccine Customers
8 Intramuscular HPV Vaccine Market Dynamics
8.1 Intramuscular HPV Vaccine Industry Trends
8.2 Intramuscular HPV Vaccine Market Drivers
8.3 Intramuscular HPV Vaccine Market Challenges
8.4 Intramuscular HPV Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
